Already on an IPO high, biotech looks for a sequel to the JOBS Act

The JOBS Act — credited for the swell in biotech initial public offerings over the past 16 months — could get a sequel...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.